Probucol disuccinate

CAS No. 216168-45-5

Probucol disuccinate( —— )

Catalog No. M18242 CAS No. 216168-45-5

Probucol is an anti-hyperlipidemic drug initially developed in the treatment of coronary artery disease by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 60 In Stock
25MG 102 In Stock
50MG 147 In Stock
100MG 225 In Stock
200MG 342 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Probucol disuccinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Probucol is an anti-hyperlipidemic drug initially developed in the treatment of coronary artery disease by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.
  • Description
    Probucol is an anti-hyperlipidemic drug initially developed in the treatment of coronary artery disease by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.
  • In Vitro
    Probucol Disuccinate is a derivative of Probucol.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    LDL
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    216168-45-5
  • Formula Weight
    716.99
  • Molecular Formula
    C39H56O8S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)c1cc(cc(c1OC(=O)CCC(=O)O)C(C)(C)C)SC(C)(C)Sc1cc(c(c(c1)C(C)(C)C)OC(=O)CCC(=O)O)C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamamoto A,et al.A uniqe antilipidemic drug--probucol. J Atheroscler Thromb. 2008 Dec;15(6):304-5. Epub 2008 Dec 11.
molnova catalog
related products
  • Rebaudioside F

    Rebaudioside F is a natural product.

  • FGIN-1-43

    FGIN-1-43 is a potent and specific ligand for the mitochondrial DBI receptor.

  • GRGDSP TFA

    GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.